| | Sex/Age | Diagnosisa/ FVP grade/activity | Pre-op BCVA | Surgical techniques during DV | BCVA with MH | Pre-MH condition | Size/Interval of MH development (mos) | MHRD | MH surgery | MH closure;BCVA; Follow-up (mos) |
| 1 | M/54 | 2, 3/not availablec | 20/100 | 1st: SOIc 2nd: SOR, ILMP | 20/400 | Foveal thinning, CME | 313/0.5 | − | Lens posterior capsular flap insertion, C3F8 | +; 20/125; 48 | 2 | F/50 | 1–3/3/active | 20/630 | 1st: FVPR, SOI 2nd: SORb | 20/200 | ERM, LMH, CME, residual FVP, foveal thinning | 308/0.75 | + | ERMR, ILMP, inverted ILM flaps insertion, C3F8 | +; 20/125; 19 | 3 | F/68 | 1–3/3/active | ND50 cm | FVPR, C3F8, ILMP | HM1m | Anterior PVR, CME | 1065/1.25 | + | Perfluorocarbon-assisted retinectomy, neurosensory retinal free flap insertion, SOI | +; 20/400; 12 | 4 | M/65 | 1, 2/2/active | 20/400 | FVPR, C3F8b | 20/1000 | ERM | 544/6.5 | − | ERMR, ILMP, C3F8 | +; 20/800; 9 | 5 | F/54 | 2–4/3/active | HM20 cm | FVPR, C3F8, ILMP | 20/200 | ERM, LMH, CME | 146/11 | − | ERMR, ILMP, C3F8 | +; 20/100; 6 | 6 | M/58 | 2, 3/2/active | 20/100 | FVPR, SOI | HM60 cm | ERM, LMH | 762/21 | − | ERMR, ILMP, C3F8 | +; ND20 cm; 6 | 7 | M/53 | 1, 2/3/active | 20/2000 | FVPR | 20/250 | ERM, LMH, CME | 209/76 | − | ERMR, ILMP, temporal inverted ILM flap, C3F8b | +; 20/63; 14 | 8 | F/60 | 1–4/4/active | HM1m | 1st: FVPR, SOI; 2nd: SOE, retinectomy, eSB; 3rd: SOE, subfoveal fibrotic band removalb | ND10 cm | ERM, LMH, anterior PVR, chronic RD, CME | 453/12 | + | SOE, ERMR, ILMP, subfoveal band removal, laser supplement at MH margin | +; ND20 cm; 6 | 9 | F/53 | 2, 3/3/active | 20/200 | 1st: FVPR, SOI, eSB 2nd: SOR, FVPR | ND10 cm | ERM | 446/36 | − | ERMR, ILMP, temporal inverted ILM flap, C3F8 | +; ND20 cm; 3 |
|
|
aDiagnosis: 1, VH; 2, FVP; 3, tractional RD; 4, rhegmatogenous RD; bcombined with cataract operation; cperformed at an outside hospital BCVA, best-corrected visual acuity; CME, cystoid macular edema; DV, diabetic vitrectomy; ERMR, epiretinal membrane removal; eSB, encircling scleral buckle; FVPR, fibrovascular proliferation removal; HM, hand motion; ILM, internal limiting membrane (ILMP, peeling); LMH, lamellar macular hole; MH, macular hole; ND, number of digits; Mos: months; PVR, proliferative vitreoretinopathy; RD, retinal detachment; VH, vitreous hemorrhage; SO, silicone oil (SOE, exchange; SOI, infusion; SOR, removal).
|